Latest Ratios: P/E Ratio 33.8x · EV/EBITDA 23.0x · ROE 38.3%. (2022–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Market Cap | $6.8B | $4.4B | $3.4B | — | — |
| Enterprise Value | $6.7B | $4.3B | $3.6B | — | — |
| P/E Ratio → | 33.78 | 21.66 | 23.40 | — | — |
| P/S Ratio | 1.82 | 1.17 | 1.18 | — | — |
| P/B Ratio | 10.84 | 6.95 | 7.95 | — | — |
| P/FCF | 75.66 | 48.64 | 29.17 | — | — |
| P/OCF | 43.42 | 27.91 | 20.55 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| EV / Revenue | — | 1.15 | 1.28 | — | — |
| EV / EBITDA | 22.98 | 14.69 | 16.89 | — | — |
| EV / EBIT | 25.48 | 14.59 | 18.66 | — | — |
| EV / FCF | — | 47.92 | 31.58 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Gross Margin | 12.1% | 12.1% | 11.9% | 11.3% | 10.2% |
| Operating Margin | 7.1% | 7.1% | 6.7% | 6.7% | 6.1% |
| Net Profit Margin | 5.4% | 5.4% | 5.0% | 4.8% | 4.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| ROE | 38.3% | 38.3% | 32.9% | 33.0% | 32.6% |
| ROA | 13.4% | 13.4% | 12.3% | 12.5% | 11.0% |
| ROIC | 31.4% | 31.4% | 20.8% | 21.1% | 18.0% |
| ROCE | 30.0% | 30.0% | 26.5% | 28.9% | 24.9% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Debt / Equity | 0.17 | 0.17 | 0.86 | 0.49 | 0.80 |
| Debt / EBITDA | 0.36 | 0.36 | 1.69 | 1.04 | 1.64 |
| Net Debt / Equity | — | -0.10 | 0.66 | 0.49 | 0.79 |
| Net Debt / EBITDA | -0.22 | -0.22 | 1.29 | 1.03 | 1.63 |
| Debt / FCF | — | -0.72 | 2.41 | 1.63 | — |
| Interest Coverage | 13.78 | 13.78 | 13.89 | 6.61 | 26.13 |
Net cash position: cash ($171M) exceeds total debt ($106M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Current Ratio | 1.76 | 1.76 | 1.79 | 1.85 | 1.66 |
| Quick Ratio | 1.70 | 1.70 | 1.70 | 1.74 | 1.59 |
| Cash Ratio | 0.23 | 0.23 | 0.17 | 0.00 | 0.00 |
| Asset Turnover | — | 2.17 | 2.21 | 2.71 | 2.38 |
| Inventory Turnover | 72.72 | 72.72 | 57.38 | 59.30 | 65.77 |
| Days Sales Outstanding | — | 75.00 | 96.97 | 85.34 | 99.51 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Earnings Yield | 3.0% | 4.6% | 4.3% | — | — |
| FCF Yield | 1.3% | 2.1% | 3.4% | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $51M | $51M | $51M | $51M |
Project billing cycle volatility
Based on current market data, ECG trades at a TTM P/E of 39.32, which appears to price in significant future earnings expansion relative to its historical baseline and broader industrial peers, suggesting investors are betting on the durability of its utility-facing project pipeline following its recent corporate spin-off.
The forward P/E of 34.33 implies that the market anticipates sustained earnings growth, yet this valuation sits at a notable premium compared to more established specialty contractors. Investors should monitor whether this multiple is supported by organic margin expansion or if it remains vulnerable to a re-rating should the company fail to meet its aggressive revenue growth targets.
As reported in financial statements, ECG's ROIC has shown a volatile trajectory, climbing from 5.2% in 2024Q1 to 11.0% in 2026Q1, indicating that the company is still in the process of optimizing its capital deployment as an independent entity rather than a subsidiary of a larger utility parent.
The improvement in ROIC suggests that management is becoming more effective at generating returns on its invested capital, though the trend remains sensitive to quarterly project mix. Sustained compounding of returns will likely depend on the company's ability to maintain high labor utilization rates while managing the overhead costs associated with its new standalone corporate structure.
According to recent quarterly data, ECG's cash conversion cycle has fluctuated significantly, with DSO reaching 67 days in 2026Q1, highlighting the inherent difficulty in managing billing cycles for large-scale utility infrastructure projects that often involve complex regulatory approval processes and extended payment terms from municipal clients.
The variability in the cash conversion cycle suggests that ECG's liquidity is highly dependent on the timing of project milestones and client payments. Analysts should scrutinize whether the recent compression in the cycle is a structural improvement or merely a temporary artifact of project timing, as persistent volatility could necessitate higher working capital reserves.
Based on reported figures, ECG maintains a disciplined debt-to-equity ratio of 0.14 as of 2026Q1, which provides a robust buffer against sector-specific cyclicality and positions the company favorably compared to more highly leveraged peers in the engineering and construction industry who face greater interest coverage risks.
This low leverage profile suggests that management is prioritizing financial stability during its early years of independence, which may provide the flexibility to pursue strategic acquisitions or return capital to shareholders. However, investors should monitor whether this conservative stance persists as the company seeks to scale its operations and compete for larger, more capital-intensive utility contracts.
The P/E ratio is frequently misapplied to ECG, as it obscures the company's underlying cash flow volatility driven by percentage-of-completion accounting and significant working capital swings that often decouple reported net income from the actual cash generated by its core utility infrastructure operations.
Instead of relying on P/E, analysts should prioritize EV/EBITDA and P/FCF to better assess the company's operational earning power and cash generation capabilities. Focusing on earnings alone may lead to an incomplete understanding of the risks associated with project-based revenue recognition and the potential for future margin compression.
Includes 30+ ratios · 4 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ECG stock.
Everus Construction Group, Inc.'s current P/E ratio is 33.8x. The historical average is 22.5x. This places it at the 100th percentile of its historical range.
Everus Construction Group, Inc.'s current EV/EBITDA is 23.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 15.8x.
Everus Construction Group, Inc.'s return on equity (ROE) is 38.3%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 34.2%.
Based on historical data, Everus Construction Group, Inc. is trading at a P/E of 33.8x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Everus Construction Group, Inc. has 12.1% gross margin and 7.1% operating margin.
Everus Construction Group, Inc.'s Debt/EBITDA ratio is 0.4x, indicating low leverage. A ratio below 2x is generally considered financially healthy.